Blue Shield of California announced a major expansion of its Virtual Blue program, more than doubling its membership by adding 260,000 new affiliates starting January 2027. The program offers unlimited virtual primary care, behavioral health, and specialty consultations with no out-of-pocket costs, often with same-day availability. This expansion includes medium-sized businesses and certain individual and family PPO plans, increasing total members with Virtual Blue from 150,000 to over 410,000. The program aims to provide accessible, affordable, and high-quality virtual healthcare, reducing costs and emergency visits while improving health outcomes through easier and earlier access to care.
Blue Shield of California's Virtual Blue program expansion is the subject. For readers following health-sector stocks, here is Pluang's market snapshot as of Sep 17, 2026 21:11 WIB: 59 of 91 priced US health stocks rose while 31 fell. Notable movers include TXG at USD 78.51 (+8.02%), SANA at USD 3.12 (+6.85%), and INO at USD 1.22 (+6.09%).
Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3), used with radiotherapy and immune checkpoint inhibitors, in 24 heavily pretreated advanced melanoma patients resistant to anti-PD-1 therapies. The treatment showed a 41.7% obj...
Genmab and Incyte announced a Phase 1/2 clinical trial to test a combination of petosemtamab, INCB161734, and standard chemotherapy as a first-line treatment for metastatic colorectal cancer with the KRAS G12D mutation. This mutation is common and li...
AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...
President Trump signed a proclamation on October 23, 2026, reshuffling which Canadian goods face his 50% tariffs, removing items like plywood and packing crates but adding others such as carpets and vinyl flooring. The broad tariffs on about $20 bill...
Injective CEO Eric Chen met with officials from the White House, SEC, and CFTC in October 2026 to discuss advancing regulated onchain finance and tokenization of real-world assets (RWAs) in the US. Injective, registered as a transfer agent by the SEC...
